Skip to menu Skip to content Skip to footer

2003

Journal Article

Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats

Osicka, Tanya M., Forbes, Josephine M., Thallas, Vicki, Brammar, Gail C., Jerums, George and Comper, Wayne D. (2003). Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats. Nephrology, 8 (4), 205-211. doi: 10.1046/j.1440-1797.2003.00159.x

Ramipril prevents microtubular changes in proximal tubules from streptozotocin diabetic rats

2003

Journal Article

Role of advanced glycation end products in diabetic nephropathy

Forbes, Josephine M., Cooper, Mark E., Oldfield, Matthew D. and Thomas, Merlin C. (2003). Role of advanced glycation end products in diabetic nephropathy. Journal of the American Society of Nephrology, 14 (suppl 3), S254-S258. doi: 10.1097/01.ASN.0000077413.41276.17

Role of advanced glycation end products in diabetic nephropathy

2003

Journal Article

Reduced tubular cation transport in diabetes: prevented by ACE inhibition

Thomas, Merlin C., Tikellis, Chris, Burns, Wendy C., Thallas, Vicki, Forbes, Josephine M., Cao, Zemin, Osicka, Tanya M., Russo, Leileata M., Jerums, George, Ghabrial, Hany, Cooper, Mark E. and Kantharidis, Phillip (2003). Reduced tubular cation transport in diabetes: prevented by ACE inhibition. Kidney International, 63 (6), 2152-2161. doi: 10.1046/j.1523-1755.2003.00006.x

Reduced tubular cation transport in diabetes: prevented by ACE inhibition

2003

Journal Article

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

Candido, Riccardo, Forbes, Josephine M., Thomas, Merlin C., Thallas, Vicki, Dean, Rachael G., Burns, Wendy C., Tikellis, Christos, Ritchie, Rebecca H., Twigg, Stephen M., Cooper, Mark E. and Burrell, Louise M. (2003). A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circulation Research, 92 (7), 785-792. doi: 10.1161/01.RES.0000065620.39919.20

A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes

2003

Journal Article

Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathy

Tikellis, Christos, Johnston, Colin I., Forbes, Josephine M., Burns, Wendy C., Burrell, Louise M., Risvanis, John and Cooper, Mark E. (2003). Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathy. Hypertension, 41 (3), 392-397. doi: 10.1161/01.HYP.0000060689.38912.CB

Characterization of renal angiotensin - converting enzyme 2 in diabetic nephropathy

2003

Journal Article

Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization

Clavant, Steven P., Forbes, Josephine M., Thallas, Vicki, Osicka, Tanya M., Jerums, George and Comper, Wayne D. (2003). Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization. Nephron, 93 (2), 51-60. doi: 10.1159/000068528

Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization

2003

Journal Article

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes

Forbes, Josephine M, Thallas, Vicki, Thomas, Merlin C, Founds, Hank W, Burns, Wendy C, Jerums, George and Cooper, Mark E (2003). The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. The FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 17 (12), 1762-1764.

The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes

2002

Journal Article

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

Twigg, Stephen M., Cao, Zemin, McLennan, Sue V., Burns, Wendy C., Brammar, Gail, Forbes, Josephine M. and Cooper, Mark E. (2002). Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. Endocrinology, 143 (12), 4907-4915. doi: 10.1210/en.2002-220619

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

2002

Journal Article

Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282))

Forbes, J. M., Cooper, M. E., Thallas, V., Burns, W. C., Thomas, M. C., Brammar, G. C., Lee, F., Grant, S. L., Burrell, L. A., Jerums, G. and Osicka, T. M. (2002). Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282)). Diabetes, 51 (12)

Erratum: Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy (Diabetes (2000) 51 (3274-3282))

2002

Journal Article

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

Forbes, Josephine M., Cooper, Mark E., Thallas, Vicki, Burns, Wendy C., Thomas, Merlin C., Brammar, Gail C., Lee, Fiona, Grant, Sharon L., Burrell, Louise M., Jerums, George and Osicka, Tanya M. (2002). Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes, 51 (11), 3274-3282. doi: 10.2337/diabetes.51.11.3274

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

2002

Conference Publication

Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.

Rizkalla, BM, Cao, ZM, Forbes, JM and Cooper, ME (2002). Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.. LIPPINCOTT WILLIAMS & WILKINS.

Pivotal role of the AT2 receptor subtype in mediating angiotensin II indiced renal VEGF expression.

2002

Conference Publication

Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.

Forbes, JM, Thallas, V, Jerums, G, Thomas, MC and Cooper, ME (2002). Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.. LIPPINCOTT WILLIAMS & WILKINS.

Renoprotection is afforded by the advanced glycation end product (AGE) cross-link breaker, ALT-711.

2002

Conference Publication

Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.

Cooper, ME, Cao, Z, Candido, R, Forbes, JM, Osicka, TM, Twigg, S and Bonnet, F (2002). Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.. 38th EASD Annual Meeting of the European-Association-for-the-Study-of-Diabetes, Budapest Hungary, Sep 01-05, 2002. SPRINGER-VERLAG.

Expression of connective tissue growth factor in the diabetic kidney: association with renal collagen synthesis.

2002

Conference Publication

Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?

Davis, BJ, Forbes, JM, Jerums, G, Cooper, ME and Allen, TJ (2002). Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?. 19th Meeting of the International-Society-for-Hypertension/12th European-Society-of-Hypertension Meeting, Prague Czech Republic, Jun 23-27, 2002. LIPPINCOTT WILLIAMS & WILKINS.

Does combined blockade of RAS and advanced glycation end-product formation confer superior renoprotection in a hypertensive model of diabetic nephropathy?

2002

Conference Publication

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

Twigg, SM, Cao, Z, Burns, WC, Brammar, G, Forbes, JM and Cooper, ME (2002). Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine. AMER DIABETES ASSOC.

Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine

2002

Journal Article

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

Forbes, Josephine M., Bonnet, Fabrice, Russo, Leileata M., Burns, Wendy C., Cao, Zemin, Candido, Riccardo, Kawachi, Hiroshi, Allen, Terri J., Cooper, Mark E., Jerums, George and Osicka, Tanya M. (2002). Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. Journal of Hypertension, 20 (5), 985-992. doi: 10.1097/00004872-200205000-00034

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

2001

Journal Article

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

Oldfield, MD, Bach, LA, Forbes, JM, Nikolic-Paterson, D, McRobert, A, Thallas, V, Atkins, RC, Osicka, T, Jerums, G and Cooper, ME (2001). Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). Journal of Clinical Investigation, 108 (12), 1853-1863. doi: 10.1172/jci11951

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

2001

Journal Article

Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function

Forbes, Josephine Maree, Hewitson, Timothy David, Becker, Gavin James and Jones, Colin Lindsay (2001). Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function. Kidney International, 59 (4), 1333-1341. doi: 10.1046/j.1523-1755.2001.0590041333.x

Simultaneous blockade of endothelin A and B receptors in ischemic acute renal failure is detrimental to long-term kidney function

2001

Journal Article

Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure

Forbes, JM, Jandeleit-Dahm, K, Allen, TJ, Hewitson, TD, Becker, GJ and Jones, CL (2001). Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure. Experimental Nephrology, 9 (5), 309-316.

Endothelin and endothelin A/B receptors are increased after ischaemic acute renal failure

2001

Journal Article

Renoprotective effects of a novel inhibitor of advanced glycation

Forbes, J. M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D. M., Vasan, S., Wagle, D., Jerums, G. and Cooper, M. E. (2001). Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia, 44 (1), 108-114. doi: 10.1007/s001250051587

Renoprotective effects of a novel inhibitor of advanced glycation